ARCHIVES

In Congress: House Subcommittee Postpones FY2000 Markup; Porter Seeks 8% increase for NIH

This article is from The Cancer Letter archive.

Vol. 25 No. 29 | July 23, 1999

Download PDF Visit The Full Archive

Related Articles

Yarbro Leaves Centers Program With Pitch for More Money for Core Grants, Community Outreach, Control

July 18, 1975

FDA Expands Nexavar Indication To Include Thyroid Cancer

December 27, 2013

Group Chairman Present A Counter-Proposal To NCI Committee

June 12, 1998

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

Study: Rencarex Treatment Efficacy Increases With CAIX Antigen Density in Tumor Tissue

March 29, 2013

New Policy on Minor Changes in Trials Requires Halt in Patient Enrollment.

April 25, 2008